Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H21NO |
Molecular Weight | 231.3333 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
InChI
InChIKey=NXNPGAAZKYDOPW-UHFFFAOYSA-N
InChI=1S/C15H21NO/c1-3-14(16-10-4-5-11-16)15(17)13-8-6-12(2)7-9-13/h6-9,14H,3-5,10-11H2,1-2H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095200 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24484988 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-4'-METHYL-.ALPHA.-PYRROLIDINOBUTIOPHENONE
Created by
admin on Sat Dec 16 08:49:43 GMT 2023 , Edited by admin on Sat Dec 16 08:49:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
B1GB3U8YGM
Created by
admin on Sat Dec 16 08:49:43 GMT 2023 , Edited by admin on Sat Dec 16 08:49:43 GMT 2023
|
PRIMARY | |||
|
732180-91-5
Created by
admin on Sat Dec 16 08:49:43 GMT 2023 , Edited by admin on Sat Dec 16 08:49:43 GMT 2023
|
PRIMARY | |||
|
1-(4-METHYLPHENYL)-2-(1-PYRROLIDINYL)-1-BUTANONE
Created by
admin on Sat Dec 16 08:49:43 GMT 2023 , Edited by admin on Sat Dec 16 08:49:43 GMT 2023
|
PRIMARY | |||
|
57486975
Created by
admin on Sat Dec 16 08:49:43 GMT 2023 , Edited by admin on Sat Dec 16 08:49:43 GMT 2023
|
PRIMARY | |||
|
DTXSID201024526
Created by
admin on Sat Dec 16 08:49:43 GMT 2023 , Edited by admin on Sat Dec 16 08:49:43 GMT 2023
|
PRIMARY | |||
|
4'-Methyl-α-pyrrolidinobutiophenone
Created by
admin on Sat Dec 16 08:49:43 GMT 2023 , Edited by admin on Sat Dec 16 08:49:43 GMT 2023
|
PRIMARY | 4'-Methyl-α-pyrrolidinobutiophenone or MPBP is a stimulant compound which has been reported as a novel designer drug. It is closely related to pyrovalerone, being simply its chain-shortened homologue. |
ACTIVE MOIETY
METABOLITE (PARENT)